Nonazotemic patients with cirrhosis and moderate ascites
Showing 26 - 50 of >10,000
Hepatic Encephalopathy Trial in Palmetto Bay (Rifaximin SSD, Placebo)
Recruiting
- Hepatic Encephalopathy
- Rifaximin SSD
- Placebo
-
Palmetto Bay, FloridaBausch Site 001
Apr 7, 2022
Microvesicles and Monocytes to Predict Mortality of Cirrhosis
Active, not recruiting
- Cirrhosis
-
Bobigny, France
- +4 more
Jan 19, 2023
Liver Cirrhosis, Spontaneous Bacterial Peritonitis Trial in New Delhi (20% High Dose Albumin, Standard Medical Treatment, 20%
Not yet recruiting
- Liver Cirrhosis
- Spontaneous Bacterial Peritonitis
- 20% High Dose Albumin
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 8, 2023
Sexual Dysfunction in Patients With Cirrhosis Awaiting Liver Transplantation Trial (questionnaire, blood collection)
Not yet recruiting
- Sexual Dysfunction in Patients With Cirrhosis Awaiting Liver Transplantation
- questionnaire
- blood collection
- (no location specified)
Jun 17, 2022
Prevalence of Pain in Hospitalized Cirrhotic Patients
Not yet recruiting
- Cirrhosis
- +4 more
- Pain evaluation
- (no location specified)
Sep 28, 2023
Cirrhosis, Liver Trial in New Delhi (Midodrine Oral Tablet, Standard Medical Treatment)
Not yet recruiting
- Cirrhosis, Liver
- Midodrine Oral Tablet
- Standard Medical Treatment
-
New Delhi, IndiaInstitute of liver and biliary sciences
Mar 11, 2022
Refractory Ascites in Children With Cirrhosis Trial in New Delhi (Midodrine, Standard medical treatment)
Recruiting
- Refractory Ascites in Children With Cirrhosis
- Midodrine
- Standard medical treatment
-
New Delhi, IndiaILBS
Nov 11, 2021
Cirrhosis, Liver, Acute-On-Chronic Liver Failure, Shock, Septic Trial in Chandigarh (20% albumin, Balanced salt solution)
Recruiting
- Cirrhosis, Liver
- +3 more
- 20% albumin
- Balanced salt solution
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jun 28, 2022
Decompensated Cirrhosis and Ascites Trial in Worldwide (Albutein 20% Injectable Solution, Standard medical treatment)
Recruiting
- Decompensated Cirrhosis and Ascites
- Albutein 20% Injectable Solution
- Standard medical treatment
-
Phoenix, Arizona
- +49 more
Jul 14, 2021
Crystalloid and Colloid I.V Fluid Therapy in Prevention of
Not yet recruiting
- Ascites
- Paracentesis
- (no location specified)
Jan 22, 2022
Cirrhosis, Ascites Hepatic Trial in Chandigarh (Dapagliflozin (10Mg Tab) along with standard medical therapy, Placebo of
Recruiting
- Cirrhosis
- Ascites Hepatic
- Dapagliflozin (10Mg Tab) along with standard medical therapy
- Placebo of dapaglifozin along with standard medical therapy
-
Chandigarh, IndiaDept of Hepatology, PGIMER
Sep 3, 2021
System of Clinical Endpoint Events for Chronic Hepatitis B
Active, not recruiting
- Chronic Hepatitis b
-
Beijing, Beijing, China
- +6 more
Sep 2, 2022
Cirrhosis, Liver Trial in Santiago (Physical and nutritional therapy)
Recruiting
- Cirrhosis, Liver
- Physical and nutritional therapy
-
Santiago, Metropolitana, ChilePontificia Universidad Catolica de Chile
Nov 27, 2023
Liver Cirrhosis Trial in New Delhi (drug, biological, other)
Recruiting
- Liver Cirrhosis
- Midodrine
- +3 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jun 12, 2021
Liver Cirrhosis Trial in New Delhi (Carvedilol, Standard Medical Treatment)
Recruiting
- Liver Cirrhosis
- Carvedilol
- Standard Medical Treatment
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Oct 21, 2021
Hepatic Encephalopathy, Cirrhosis, Liver, Portal Hypertension Trial in Belgium, Netherlands (Rifaximin 550 milligram Oral Tablet
Recruiting
- Hepatic Encephalopathy
- +4 more
- Rifaximin 550 milligram Oral Tablet [XIFAXAN]
- +2 more
-
Leuven, Belgium
- +5 more
Feb 15, 2022
Liver Cirrhosis, Fibrosis, End Stage Liver Disease Trial in Chandigarh (Growth Hormone)
Recruiting
- Liver Cirrhosis
- +6 more
- Growth Hormone
-
Chandigarh, UT, IndiaPostgraduate Institute of Medical education and Research
Mar 26, 2022
Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)
Not yet recruiting
- Hepatic Ascites
- Recombinant Human Serum Albumin
- Human serum albumin
-
Guangdong, Shenzhen, ChinaShenzhen Protgen Ltd
May 5, 2023
Gastric Cancer, Peritoneal Metastases, Ascites, Malignant Trial in Hangzhou (Sintilimab in Combination With S-1/oxaliplatin With
Recruiting
- Gastric Cancer
- +2 more
- Sintilimab in Combination With S-1/oxaliplatin With nab-paclitaxel intraperitoneal infusion
- Blood samples, tumor biopsy specimens, ascites, and feces samples will be collected
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 18, 2023
Long Term Follow up of Chronic HCV Patients Receiving DAAS
Recruiting
- Chronic Hepatitis c
-
Sohag, EgyptSohag University Hospital
Jun 29, 2022